Top

Neuroscience Bulletin

Published in:

01-10-2018 | Letter to the Editor

Identification of Abnormal 51 CTA/CTG Expansion as Probably the Shortest Pathogenic Allele for Spinocerebellar Ataxia-8 in China

Authors: Minjin Wang, Shuo Guo, Wencong Yao, Jun Wang, Jianxia Tao, Yanbing Zhou, Binwu Ying

Published in: Neuroscience Bulletin | Issue 5/2018

Excerpt

Dear Editor, …

Available only for authorised users

Muso Z, Sedlacek Z, Mazanec R, Klempir J, Roth J, Plevova P, et al. Spinocerebellar ataxias type 8, 12, and 17 and dentatorubro–pallidoluysian atrophy in Czech ataxic patients. Cerebellum 2013, 12:155–161.CrossRef

Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, et al. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 2004, 75: 3–16.CrossRefPubMedPubMedCentral

Mariotti C, Di Donato S. Cerebellar/spinocerebellar syndromes. Neurol Sci 2001, 22 Suppl 2: S88–S92.CrossRefPubMed

Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999, 21: 379–384.CrossRefPubMed

Silveira I, Alonso I, Guimaraes L, Mendonca P, Santos C, Maciel P, et al. High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. Am J Hum Genet 2000, 66: 830–840.CrossRefPubMedPubMedCentral

Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006, 38: 758–769.CrossRefPubMed

Moseley ML, Schut LJ, Bird TD, Koob MD, Day JW, Ranum LP. SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. Hum Mol Genet 2000, 9: 2125–2130.CrossRefPubMed

Musova Z, Sedlacek Z,Mazanec R, Klempir J, Roth J, Plevova P, et al. Spinocerebellar ataxias type 8, 12, and 17 and dentatorubro–pallidoluysian atrophy in Czech ataxic patients. Cerebellum 2013, 12: 155–161.CrossRefPubMed

Munhoz RP, Teive HA, Raskin S, Werneck LC. CTA/CTG expansionsat the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 2009, 111: 208–210.CrossRefPubMed

10.

Cintra VP, Lourenço CM, Rocha MM, Tomaselli PJ, Marques W. Analysis of a fully penetrant spinocerebellar ataxia type 8 Brazilian family. Acta Neurol Scand 2017, 136: 541–545.CrossRefPubMed

11.

Juvonen V, Hietala M, Päivärinta M, Rantamäki M, Hakamies L, Kaakkola S, et al. Clinical and genetic findingsin Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol 2000, 48: 354–361.CrossRefPubMed

Title: Identification of Abnormal 51 CTA/CTG Expansion as Probably the Shortest Pathogenic Allele for Spinocerebellar Ataxia-8 in China
Authors: Minjin Wang
Shuo Guo
Wencong Yao
Jun Wang
Jianxia Tao
Yanbing Zhou
Binwu Ying
Publication date: 01-10-2018
Publisher: Springer Singapore
Published in: Neuroscience Bulletin / Issue 5/2018
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218
DOI: https://doi.org/10.1007/s12264-018-0247-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Identification of Abnormal 51 CTA/CTG Expansion as Probably the Shortest Pathogenic Allele for Spinocerebellar Ataxia-8 in China

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2018

Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer’s Disease

Spatiotemporal Imaging of Cellular Energy Metabolism with Genetically-Encoded Fluorescent Sensors in Brain

SIRT1 rs3758391 and Major Depressive Disorder: New Data and Meta-Analysis

Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C

A Novel MYCN Variant Associated with Intellectual Disability Regulates Neuronal Development

Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington’s Disease